Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx

Hepatitis B virus (HBV) remains a major cause of hepatic disease that threatens human health worldwide. Type I IFN (IFN-I) therapy is an important therapeutic option for HBV patients. The antiviral effect of IFN is mainly mediated via upregulation of the expressions of the downstream IFN-stimulated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Tan, Guangyun, Xu, Fengchao, Song, Hongxiao, Yuan, Ye, Xiao, Qingfei, Ma, Feng, Qin, F. Xiao-Feng, Cheng, Genhong
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6100580/
https://ncbi.nlm.nih.gov/pubmed/30150992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01872
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky